Lyme borreliosis (LB)1 is a multisystemic inflammatory disorder caused by the spirochete Borrelia burgdorferi (1) (2) (3) . Previous studies have shown that most patients with LB develop an early and strong cellular immune reactivity to B. burgdorferi, which in early stages often precedes an only slowly evolving humoral response (4) (5) (6) (7) . Although the spectrum ofspecific antibodies against B. burgdorferi has been recognized in several studies (8) (9) (10) (11) (12) , only little is known about the immunodominant T cell antigens. Two major proteins of B. burgdorferi, the outer surface protein A (OspA) and flagellin, appear to be of particular interest. The species-specific OspA is a 31 -kD protein that is expressed in large amounts on the outer membrane of B. burgdorferi. OspA has been described to be antigenically variable between different isolates of B. burgdorferi (1 1, 13, 14) . In mice experimentally inoculated with whole borreliae or with recombinant protein, OspA induces a vigorous humoral immune response ( 15, 16) . In the severe combined immunodeficiency mouse model for LB ( 17) , the manifestation of the disease could be prevented or mitigated by the application of anti-OspA antibodies when administered together with the causing agent ( 16, 18) . Moreover, active immunization of immunocompetent mice with recombinant OspA induced the production of anti-OspA antibodies and protected from challenge with B. burgdorferi, making OspA a possible candidate for a vaccine ( 15, 16) . However, in humans the humoral response to OspA as detected by immunoblotting is quite rare, and if present develops only at later stages (3, 5, 8, 9, 12) . In contrast, antibodies to flagellin, a 41-kD protein associated with the flagella of B. burgdorferi, are detectable in nearly all patients with LB even in early stages of the disease ( 19, 20) . However, flagellin from B. burgdorferi shows high protein sequence homologies with similar proteins from other spirochetes and bacteria not related to B. burgdorferi, which may lead to serological cross-reactivities ( 19, (21) (22) (23) (24) .
Recently, the genes for OspA (from the German isolate ZS7) (25) and for flagellin (from the American isolate B3 1) (22) have been cloned by ourselves and by other groups (23, 26) and proteins have been produced in a recombinant, highly purified form (16, 22) . Based upon our previous findings of high T cell responses towards whole B. burgdorferi bacteria (4) , the objective of this investigation was to further define the differential cellular immune reactivities towards OspA and flagellin in patients with different clinical stages of LB. These findings were compared with the humoral responses as determined by immunofluorescence tests and Western blot analysis using the two domestic B. burgdorferi strains ZS7 and PKo
2-85.
The results obtained demonstrate that patients with early and late infections of LB show a significantly elevated cellular immune response to B. burgdorferi, which is in part directed against OspA and flagellin. Furthermore, the data provide evidence for a dissociation between the presence of B. burgdorferi specific antibodies and T cell reactivities in early and late stages of LB.
Methods
Patients and control subjects. In 36 patients with LB and 25 control subjects the cellular immune response to B. burgdorferi antigens was studied. The clinical characteristics ofpatients and controls are summarized in Table I . All individuals tested were newly entered into the study and therefore represent populations additional to the ones previously reported (4). 1 1 patients had early infections (disease stages 1 and 2 according to Steere [ 3 ] ) at the time of study (group 1) with erythema migrans (n = 7), lymphadenosis cutis benigna (n = 2), meningopolyneuritis (n = 1), and chorioditis (n = 1). Of interest, the latter patient later developed severe arthritis and B. burgdorferi was cultured from synovectomy material. Six of the 11 patients had detectable antibodies against B. burgdorferi in an immunofluorescence assay (IFA) (4) . The time elapsed between a recognized tick or insect bite and the examination of these patients ranged from 3 to 90 d.
The remaining 25 LB patients suffered from late stage disease (group 2) (3), including Lyme arthritis (n = 23) and localized scleroderma like skin lesions (n = 2). 20 patients were seropositive and 5 were seronegative in the IFA. In the seronegative patients the diagnosis oflate LB was based on a typical history ofan erythema migrans in four patients, among these was one patient with a complete heart block. One additional seronegative patient had been seropositive before therapy with antibiotics but had converted to seronegative after therapy despite persistance ofclinical symptoms. Ofthe seropositive patients seven had additional previous or concomitant symptoms ofLB: two had a history of a recognized erythema migrans, one had acrodermatitis, and four had had typical meningopolyneuritis with specific antibodies in the spinal fluid. In the sera of the remaining patients high IgG antibody titers (2 1:256 in IFA) against B. burgdorferi were detectable and in three individuals specific IgM antibodies were found. B. burgdorferi was cultured from a synovectomy specimen from one patient, and five individuals showed improvement after ceftriaxone therapy.
Most LB patients ofboth groups complained about additional constitutional symptoms of different intensities. 2 patients of group 1 and 13 patients of group 2, including the 5 seronegative individuals, had previously been treated with antibiotics, generally doxycycline or penicillin. However, in all patients symptoms ofactive LB were still present at the time of investigation, indicating active disease.
Two control groups were established. One group (group 3) consisted of 13 patients with different inflammatory disorders who had initially attended our clinic because of suspected LB but in whom LB was subsequently excluded. Of these, three had RA according to the American College ofRheumatology criteria (27) , seven presented with HLA B27-associated reactive arthritis, two had inflammatory skin lesions (one lichen sclerosus et atrophicus, one allergic skin reaction) not related to borrelia infections, and one suffered from a neuritis nervi optici. In five patients (two seropositive RA, two classical Reiter's syndrome associated with chlamydial infections, one neuritis nervi optici), significant amounts of IgG antibodies against B. burgdorferi were determined, but there were no anamnestic or clinical criteria for active LB. Moreover, none of the patients had responded to recommended regimens of antibiotic treatment.
The second control group (group 4) included 12 healthy individuals. All healthy donors (HD) were negative for serum antibodies against B. burgdorferi. Members of our laboratories who work with B. burgdorferi were excluded from this group (28) .
Expression andpurification ofrecombinant B. burgdorferi proteins. Escherichia coli transformed by the bacterial expression vector pUEXI and subsequently expressing OspA or 41 -kD flagellin were grown overnight at 30°C in 10 ml Luria-Bertani broth with ampicillin (29) . 1 ml ofovernight cultures was expanded in 100 ml ofmedium and grown at 30°C with good aeration to a density of 8 x I07 cells/ml (A6W = 0.2).
Expression of recombinant 41-kD flagellin was achieved by transferring the cells to 42°C for 2 h. After washing the cells in STE buffer (10 mM Tris, 100 mM NaCl, 1 mM EDTA, pH 8.0) the pellet was resuspended in 0.6 ml lysisbuffer(25% sucrose/50 mM TrispH 8.0). 150 Al oflysozyme ( 10 mg/ml) were added and the mixture was incubated for 15 min on ice followed by another 15 min incubation on ice with 18 Mll DNaseI (10 mg/ml) and 5 ,ul 1 M MgCl2. Finally, 250 Mi of 4 X detergent mix ( 1% Triton X-100, 0.5% Deoxycholate, 0.1 M NaCl, 10 mM Tris, pH 7.4) were added and incubated for 5 min on ice. After centrifugation, pellets were washed twice in buffer A (50 mM Tris, 50 mM NaCl, 1 mM EDTA, pH 8.0), resuspended with 9 vol of buffer A containing 8 M urea and incubated for 1 h at room temperature. The samples were diluted with nine parts of buffer B (50 mM KH2PO4-K2HPO4, pH 10.7, 50 mM NaCl, 1 mM Tris) and stirred for 30 min at room temperature while keeping the pH at 10.7 by adding KOH. After adjusting the pH of the solution to 7.0 by the addition of HCI, the samples were dialyzed overnight in the cold against buffer A. Solutions were centrifuged for 10 min at 10,000 g (4°C), and the supernatants were further purified by antibody affinity chromatography. Recombi (22) monoclonal antibody column (3 ml at 10 mg/ml). The column was washed with five column volumes of PBS and the bound material was then eluted using 0.1 M glycine/HCl, pH 3.0. Finally, the recombinant antigens purified by chromatography were dialyzed against PBS ( 16) . Purity of antigens was tested by SDS-PAGE and silver staining, revealing only very faint contaminating bands. Moreover, cellular immune responses were studied initially using whole urea lysates oftransformed E. coli and demonstrated only minor T cell reactivities that were not different between normal donors and patients. Lymphocyte proliferation assay. The lymphocyte proliferation assay was performed as described previously (4) . PBMCs were isolated from heparinized peripheral venous blood by standard centrifugation on a Ficoll-Hypaque (Nycomed Pharma, Oslo, Norway) gradient. They were resuspended in RPMI 1640 medium (Biochrom KG, Berlin, Germany) supplemented with L-Glutamin (2 mM, Sigma Chemical Co., St. Louis, MO), Hepes buffer ( 15 mM, Gibco Laboratories, Eggenstein, Germany), penicillin/streptomycin ( 100 IU/ml and 100 ,qg/ml, respectively; Gibco Laboratories), and 10% autologous serum and cultured in triplicate at a concentration of 1 x 105 cells/well in round-bottom microtiter plates (Nunc, Roskilde, Denmark). Cells were stimulated with whole B. burgdorferi (German isolate PKo 2-85, kindly provided by Dr. Vera Preac-Mursic, Max-von-Pettenkofer-Institute, Munich, Germany) (30) at concentrations of 1 X 105 and 1 X 106 bacteria/well (corresponding to 0.3 and 3 Ag protein/well, respectively) or with recombinant 31-and 41-kD proteins at final concentrations of 10, 1, 0.1, and 0.01 ug/ml. In previous experiments the T cell nature of the cellular response to B. burgdorferi antigens had already been demonstrated since only purified T cells but not the non-T cell fraction proliferated in response to stimulation with B. burgdorferi (4) . Control cultures received medium alone or ultrasonicated Treponema phagedenis (Behringwerke, Marburg, Germany) at 7 and 0.7 Mg/well. The latter spirochete is ofthe same family as B. burgdorferi and was used as a control antigen. All antigen concentrations had been tested in dose-response experiments and had been found to induce optimal and maximum stimulations in either of the concentrations mentioned above. Therefore, various concentrations were used throughout the experiments. Cultures were incubated at 37°C in a humidified atmosphere with 5% CO2 for 6 d. Subsequently, 1 MCi of [3H]thymidine (sp act 2 Ci/mmol; Amersham Buchler, Braunschweig, Germany) was added to each well for 18 h. Cells were harvested semiautomatically and tritiated thymidine incorporation was determined in a liquid scintillation counter (LKB Wallac, Turku, Finland). Results were expressed as average disintegration per minute ([dpm] quench correction by an internal standard) of triplicate wells. Adpm was calculated by subtracting the control values with medium alone from the dpm obtained in the presence of antigen. In all experiments, for each of the stimuli, i.e., whole borreliae, sonicated T. phagedenis, and recombinant proteins, only the maximum values of all concentrations tested will be shown.
Western blot analysis. Sera from all 36 patients with LB (groups 1 and 2) and from 12 non-LB patients (group 3) were obtained on the same day as the PBMCs and were subjected to immunoblot analysis for specific antibodies against B. burgdorferi. Since there may be antigenic heterogeneity between borrelia strains, resulting in different results in the immunoblots (11, 12, 31) , two different german B. burgdorferi isolates PKo (30) and ZS7 (17) (from which the gene for the recombinant OspA had been cloned) were used as antigens. In brief, whole borreliae were lysed in Tris/glycerin/SDS buffer, the protein concentration was determined, and 5 Mg protein/lane were separated by SDS-PAGE with 10 or 12% polyacrylamide running gels as described by Laemmli (32) . Proteins were transferred to nitrocellulose and, after blocking with 0.1% bovine serum albumin or with 3% gelatin, incubated with the sera at a 1:100 dilution. Bound immunoglobulins were visualized with appropriate peroxidase-conjugated goat anti-human immunoglobulin antibodies. Based upon own observations with patient and control sera (unpublished data) and according to the suggestions of Zoller et al. (12) as well as Grodzicki and Steere (9) , blots fulfilling one of the following criteria were considered positive: (a) in early disease stages a clear 41-kD band and at least two additional bands with one band corresponding to the 21-, 30-, 60-, or 87-kD protein; (b) in late LB five or more antibodies against B. burgdorferi proteins with a strong 18-, 21-, 23-, 30-, 41-, 75-, or 87-kD band. For further evaluation, special attention was placed on the presence ofantibodies against OspA and flagellin.
Immunofluorescence assay. The IFA was performed as described previously (4) . All sera were preabsorbed with T. phagedenis before testing in order to eliminate cross-reacting antibodies. After this procedure, the IFA was highly specific for B. burgdorferi, and there virtually was no cross-reaction to other spirochetes, especially Treponema pallidum. In a random Bavarian (Franconian) population (n = 334) matched for similar living areas as the patient population, 276 (83%) were seronegative, 33 (10%) had titers of 1:16, 6 (2%) of 1:32, 10 (3%) of 1:64, and 9 (3%) of 2 1:128. Therefore, in the clinical situation, titers from 1:64 on were regarded as indicative of a definite serological reaction (10) . For the detection of specific IgM antibodies, sera were additionally pretreated with rheumatoid factor absorbent (Behringwerke) to prevent false-positive results due to rheumatoid factor absorbent or false-negative results because of competitive inhibition by specific IgG.
Statistical analysis. Data are presented as median values (range) unless otherwise indicated. The proliferation values of the four groups tested were compared by the Mann-Whitney U test, and P values of < 0.05 were considered to be significant. Correlations between response values to different antigens within the study groups were determined by the Spearman rank correlation test. Correlation coefficients were considered significant at P < 0.01.
Results
T cell response towards whole B. burgdorferi and T. phagedenis. The cellular immune responses to in vitro stimulation with whole B. burgdorferi bacteria were significantly elevated in patients with early (median 37,700 dpm) and with late LB (median 40,000 dpm) as compared with non-LB patients (median 13,200 dpm, P < 0.0005) or HD (median 18,000 dpm, P < 0.002) (Fig. 1 A; Table II ). This increased lymphoproliferative response did not correlate with the presence of specific antibodies against B. burgdorferi and was already detectable as early as 2 d after the onset of the erythema migrans. No significant differences in proliferation values were observed either between patients with early and late infections or between non-LB patients and HD. Despite highly significant differences in response rates between LB patients and control subjects, the majority of control individuals showed responses to whole B. burgdorferi, which, however, generally were marginal in magnitude (Fig. 1 A) .
In contrast to B. burgdorferi, stimulation of PBMC with T. phagedenis generally resulted in moderate proliferative responses in all four groups tested. Only in patients with LB and irrespective ofthe disease stage did T cell proliferation induced by B. burgdorferi always exceed responses elicited by stimulation with T. phagedenis (early: median values 37,700 vs. 7,800 dpm, P < 0.004, late: 40,000 vs. 9,400 dpm, P < 0.0001 ) (Fig.  1, A and B ; Table II). T cell responses to recombinant OspA andflagellin. Fig. 1 16,000 dpm) compared with non-LB patients (median 4,400 dpm, P < 0.002) and HD (median 5,000 dpm, P < 0.02) ( In contrast, T cell responses to flagellin (Fig. D) were significantly elevated only in patients with early LB (median 22,700 dpm) and exceeded the proliferation values of the two control groups (group 3: median 8,000 dpm, P < 0.008; group 4: median 11,300 dpm, P < 0.05). Responses of late LB patients (median 12,300) did not significantly differ from those of patients with early LB or of the control groups (Table II) . Only two patients with early LB, eight individuals with late infection, six non-LB patients, and three HD showed low responses of < 5,000 dpm, whereas the majority of individuals tested responded well (> 10,000 dpm) to flagellin. One to stimulation with whole B. burgdorferi. In the control groups, T cells derived from 4 of 13 non-LB patients and 6 of 12 HD showed response values to flagellin above the median value of late LB patients (Fig. 1 D; Table II) . Table III shows that in patients with LB there were strong, consistent, and significant correlations between T cell responses to the spirochetal antigens tested. In contrast, in healthy donors and non-LB patients generally no consistent correlations were observed. Here, only responses to B. burgdorferi and T. phagedenis correlated significantly (r = 0.70, P < 0.01 ) in non-LB patients, whereas in HD a very strong and highly significant correlation was observed between proliferation values after stimulation with T phagedenis and OspA (r =0.91, P <0.001).
Humoral immune responses to B. burgdorferi proteins. Of the six patients with early LB who were seropositive in the IFA, three showed a restricted antibody pattern with bands corresponding to the 41-kD protein and one or two additional bands, whereas the remaining three individuals showed an extended pattern of more than five antigens recognized (Fig. 2) . Two of five individuals with negative IFA immunoblots were considered positive according to the criteria mentioned in Methods. These sera had also been analyzed without preabsorption, again yielding negative results in the IFA. Antibodies against the 31 -kD protein were not detectable and there were no major differences between blots using strains PKo or ZS7.
In the group ofpatients with late LB (group 2), all ofthe 20 IFA-positive patients also had positive immunoblots revealing at least 5, and in some cases > 10, intense bands. All but 3 seropositive patients exhibited antiflagellin antibodies, and 16 individuals showed antibodies against a 87-kD protein. Antibodies against OspA of PKo were found in only four patients; antibodies against OspA of ZS7 were found in only three individuals. In these patients, T cell proliferation values to OspA were 24,300, 14,600, 12,400 dpm, and, interestingly, in one patient T cells did not react to OspA at all. It is noteworthy that in most individuals antibodies against a 30-kD protein were observed as has been described by others ( 12) . This protein could be clearly distinguished from OspA with sera-containing antibodies against both proteins and by additional experiments using monoclonal antibodies. Moreover, on most blots OspA could easily be recognized by a light, "negatively stained" band with missing background staining activity of the nitrocellulose strip due to the presence of high amounts of this protein (Fig. 2) .
In group 3 (non-LB patients), positive immunoblots were observed in all five seropositive patients. These blots generally showed bands corresponding to flagellin and four or more additional bands. As in early LB, antibodies against OspA were not detectable. In the majority ofthe seronegative patients with LB, non-LB patients and HD weak 4 1-kD bands and sometimes faint additional bands were observed (Fig. 2) .
Complexity ofhumoral and cellular responses. In Table IV , results oflymphocyte proliferation assays and serological analyses of individual patients are outlined, demonstrating the complexity of cellular and humoral responses against components ofB. burgdorferi. In the early LB group (group 1 ), i. e., patients 2, 3, and 4 exhibited high T cell reactivities but differed remarkably in antibody responses. In contrast, patient 1 showed a weak cellular response in spite of a high antibody titer. In patients with late infections (group 2), almost all combinations of high and low responses could be observed and no consistent correlations between T cell reactivities to B. burgdorferi proteins or between humoral and cellular responses were detectable. Obviously, the cellular immune response to B. burgdor- Analysis ofcellular responses in the control groups revealed that T cell reactivity to OspA was not restricted to LB patients but was also detectable in healthy donors and in patients with other inflammatory diseases. In HD there was a highly significant correlation between T cell responses to OspA and to T. phagedenis. These results suggest that other saprophytic spirochetes share T cell epitopes with OspA from B. burgdorferi. This assumption is supported by recent observations by Magnarelli et al. (24) and Cooke et al. (34) demonstrating antibody cross-reactivity between B. burgdorferi and Treponema, i.e., Treponema denticola. The latter agent is a saprophyte of the human oral mucosa and is frequently found in periodontitis. It may therefore also trigger cellular cross-reactions.
However, despite these possible cross-reactions, it was clearly evident that the T cell reactivity to whole B. burgdorferi and to OspA was significantly elevated in patients with LB. Although OspA and flagellin may not be the ideal antigens to unequivocally link the respective proliferative responses to B. burgdorferi, our findings suggest that in the future a panel of standardized recombinant proteins may function as surrogates for whole B. burgdorferi. Taken together, the analysis of the T cell reactivity will not only provide significant insights into the pathogenic disease mechanisms but, especially in view of the complexity ofthe humoral and the cellular immune responses, also appears to be an important tool for the diagnosis of LB.
